DentalCare Logo
CE564 main

Laser Therapy for Adjunctive Treatment of Peri-Implant Disease

COURSE NUMBER: 564

Maria (Mia) L. Geisinger, DDS, MS

Credit Hours:

2 Hour(s)

PDF

This course seeks to evaluate the effectiveness of implant surface decontamination therapies for treatment of peri-implant disease.


The placement of endosseous dental implants is a well-accepted treatment option for edentulism as implants ...

View More

(Use this feature to create assignments for your students and staff.)

Overview

This course seeks to evaluate the effectiveness of implant surface decontamination therapies for treatment of peri-implant disease.


The placement of endosseous dental implants is a well-accepted treatment option for edentulism as implants have demonstrated high survival rates over long periods of time.1 Dental implants are a common and growing treatment modality and it is estimated that up to 5 million dental implants are placed each year.2 While dental implant survival rates remain high, reports indicate that a significant proportion of dental implants will develop peri-implant mucositis and peri-implantitis.3-6 Prevalence data for peri-implant disease is heterogeneous, but estimates suggest that the prevalence of peri-implant mucositis and peri-implantitis range from 46-63% and 19-23%, respectively.7 Inflammatory implant diseases are progressive and it has been shown that the inflammatory lesions associated with peri-implant diseases are larger than those around teeth with similar clinical presentation.8,9 There are several risk factors that can lead to inflammation, peri-implant mucositis, and, later, peri-implantitis.4,10-12 Systemic and environmental factors may play a secondary role in disease progression and susceptibility, but peri-implant diseases are initiated by accumulation of bacterial biofilm.4,13,14 As bacterial plaque is the primary etiology for peri-implant disease, current therapies for peri-implantitis require dental plaque removal and implant surface detoxification as a critical step for successful surgical and/or nonsurgical treatment of peri-implantitis.15,16 This surface detoxification has been accomplished with physical, chemical, laser therapy, and/or other means.


Treatment of peri-implantitis is unpredictable. It has been reported that even with strict supportive peri-implant therapy after active treatment for peri-implant disease, complete resolution of disease is not achieved in the majority of cases over the long term.17,18 Given the paucity of evidence for efficacious treatments of peri-implant disease, it is imperative that clinicians monitor and prevent the development of inflammation and provide intervention at the earliest possible time in the disease process. Further, critical evaluation of available treatment modalities is imperative to understand best practices for treatment of implant diseases.

  • Intended Audience:

    Dentists, Dental Hygienists, Dental Students, Dental Hygiene Students

  • Date Course Online:

    Feb 1, 2019

  • Last Revision Date:

    Feb 8, 2022

  • Course Expiration Date:

    Mar 31, 2025

  • Cost:

    Free

  • Method:

    Self-instructional

  • AGD Subject Code(s):

    135, 10, 690

  • Technical Requirements:

    Stable internet connection and the latest version of browser and device software are recommended.

Learning Objectives

Upon the completion of this course, the dental professional should be able to:


  • Understand the current scientific literature about the prevalence, etiology, and stages of peri-implant diseases.
  • Recognize, assess, and develop treatment and preventative strategies for peri-implant diseases.
  • Evaluate the available evidence regarding the efficacy of implant surface disinfection treatments to be performed as a part of surgical and nonsurgical treatment of peri-implant diseases.
  • Discuss risks, benefits and therapeutic options with patients prior to implant therapy or with peri-implant diseases.

Disclaimers

  • P&G is providing these resource materials to dental professionals. We do not own this content nor are we responsible for any material herein.

  • Participants must always be aware of the hazards of using limited knowledge in integrating new techniques or procedures into their practice.  Only sound evidence-based dentistry should be used in patient therapy.


Note:  Registration is required to take test.

Author(s)

Conflict of Interest Disclosure Statement

  • Dr. Geisinger does not have any conflicts of interest in regard to the topic of this course. She has no relevant financial relationships to disclose.

Mia L. Geisinger, DDS, MS is a Professor and Director of Advanced Education in Periodontology in the Department of Periodontology in the University of Alabama at Birmingham (UAB) School of Dentistry. Dr. Geisinger received her BS in Biology ...

View More

Submission Information

Academy of General Dentistry (AGD) Submission For credit transfers to appear in your AGD account in real time, make sure to add your AGD membership number in the field provided on the “Share Your Test Score” page.


CE Broker For all states that use CE Broker for licensure, “proof of completions” are electronically reported the first of every month. If a course was taken in November, the “proof of completion” will be submitted the beginning of December.

Recognition

AGD Pace Logo

Approved PACE Program Provider

THE PROCTER & GAMBLE COMPANY


Nationally Approved PACE Program Provider for FAGD/MAGD credit.

Approval does not imply acceptance by any regulatory authority or AGD endorsement.


8/1/2021 to 7/31/2027

Provider ID# 211886

AADH Logo

AADH Approved Program Provider

Procter & Gamble is designated as an approved Provider by the American Academy of Dental Hygiene, Inc. #AADHPGC (January 1, 2024-December 31, 2025). Approval does not imply acceptance by a state or provincial Board of Dentistry. Licensee should maintain this document in the event of an audit.